PetVivo Holdings, Inc. cotiza a 0.69 USD y tiene una capitalización bursátil de $26M. En los últimos 12 meses ha facturado $1M con un margen de flujo de caja libre del -535.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such …
| Periodo | 2026-08 | 2024-06 | 2023-06 | 2023-02 |
|---|---|---|---|---|
| Real | — | $-0.14 | $-0.21 | $-0.23 |
| Estimado | — | $-0.32 | $-0.21 | $-0.23 |
| Sorpresa | — | +56.3% | +0.0% | +0.0% |
| Métrica | PETV | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 66.1% | 57.0% | +9.1% |
| Operating Margin | -793.9% | -38.6% | -755.3% |
| Net Margin | -917.5% | -33.6% | -883.9% |
| FCF Margin | -535.6% | -13.9% | -521.8% |
| ROE | -476.2% | -40.4% | -435.8% |
| ROA | -292.8% | -32.0% | -260.8% |
| Current Ratio | 1.35 | 2.84 | -1.49 |
| Debt / Equity | — | 0.28 | — |